Skip to content
Disclosery

Nextech Invest Ltd.

Follow

13F filer, CIK 1911010, Zurich, Switzerland

Nextech Invest Ltd. reported $594,463,863 across 13 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-14. Its ten largest share positions make up 93.96% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-089665

Period
2024-06-30
Reported value
$594M
Holdings
13
Top 10 weight
93.96%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CNTXnew+7,419,355$14.9M
Mersana Therapeutics Incadded+5,669,825$11.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0001104659-24-089665, largest first. % of portfolio is the value over $594,463,863, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 4,839,529 shares; 2023Q2: 4,839,529 shares; 2023Q3: 4,839,529 shares; 2023Q4: 6,296,740 shares; 2024Q1: 6,296,740 shares; 2024Q2: 6,296,740 shares 6,296,740$244M41.11%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,518,582 shares; 2023Q2: 2,518,582 shares; 2023Q3: 2,518,582 shares; 2023Q4: 2,518,582 shares; 2024Q1: 4,055,861 shares; 2024Q2: 4,055,861 shares 4,055,861$64.9M10.91%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 5,533,980 shares; 2023Q4: 5,533,980 shares; 2024Q1: 5,533,980 shares; 2024Q2: 5,533,980 shares 5,533,980$47.5M7.99%0Timeline
CARGO THERAPEUTICS INC COMCARGO THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 2,642,502 shares; 2024Q1: 2,642,502 shares; 2024Q2: 2,642,502 shares 2,642,502$43.4M7.3%0
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 287,251 shares; 2023Q2: 287,251 shares; 2023Q3: 287,251 shares; 2023Q4: 1,695,645 shares; 2024Q1: 1,408,394 shares; 2024Q2: 1,408,394 shares 1,408,394$37.5M6.31%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 4,285,714 shares; 2023Q3: 4,285,714 shares; 2023Q4: 4,285,714 shares; 2024Q1: 5,285,714 shares; 2024Q2: 5,285,714 shares 5,285,714$37.4M6.29%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 625,485 shares; 2023Q2: 948,659 shares; 2023Q3: 1,196,409 shares; 2023Q4: 1,346,409 shares; 2024Q1: 3,846,409 shares; 2024Q2: 3,846,409 shares 3,846,409$25.1M4.22%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,221,145 shares; 2023Q2: 1,221,145 shares; 2023Q3: 1,221,145 shares; 2023Q4: 1,221,145 shares; 2024Q1: 1,221,145 shares; 2024Q2: 1,221,145 shares 1,221,145$21.3M3.58%0Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 5,978,327 shares; 2024Q1: 3,856,321 shares; 2024Q2: 9,526,146 shares 9,526,146$19.1M3.22%+5,669,825
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 952,400 shares; 2024Q2: 952,400 shares 952,400$18.1M3.04%0Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,910,029 shares; 2023Q2: 1,910,029 shares; 2023Q3: 1,910,029 shares; 2023Q4: 1,910,029 shares; 2024Q1: 1,910,029 shares; 2024Q2: 1,910,029 shares 1,910,029$16.3M2.73%0Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 7,419,355 shares 7,419,355$14.9M2.5%newTimeline
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,228,069 shares; 2024Q2: 1,228,069 shares 1,228,069$4.75M0.8%0Timeline

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-089665 base2024-08-14acceptance time not in the bulk data set